The Federal Government of Nigeria has officially launched Lenacapavir, a twice-yearly HIV prevention injection, in a move aimed at strengthening the country’s response to HIV/AIDS.
The launch, which took place on March 24, 2026, in Abuja, was carried out through the Minister of Health and Social Welfare, Muhammad Ali Pate. The initiative forms part of the Federal Government’s Renewed Hope Agenda and underscores Nigeria’s commitment to ending HIV/AIDS as a public health threat.
Health authorities emphasized that Lenacapavir is not a cure for HIV/AIDS. However, when properly administered, it has been proven to be highly effective in preventing HIV infection.
Pilot Rollout Across Selected States.
The government disclosed that the intervention is currently in its pilot phase, covering seven states and the Federal Capital Territory. The states include Benue State, Kwara State, Akwa Ibom State, Cross River State, Gombe State, Anambra State, and Ebonyi State, alongside the Federal Capital Territory.
How the Injection Works
Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) administered once every six months. Experts say the injection provides a high level of protection against HIV when taken as prescribed, offering a more convenient alternative to daily preventive medications.
The Federal Government noted that the introduction of the injectable prevention method is expected to improve adherence, expand access to HIV prevention services, and significantly reduce new infections across the country.
The pilot programme will be closely monitored, with plans for a nationwide scale-up based on its success and impact.
